Masliah et al. indicated that immunization of PD transgenic (PD/Tg) mice with full-length human α-synuclein could reduce misfolded α-synuclein accumulates in neuronal cell bodies and synapses, and also reduced neurodegeneration in a human α-synuclein transgenic PD mouse model [26]. This evidence concerns the gene SNCA and Parkinson disease.